Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Influence of diet on acute endocannabinoidome mediator levels post exercise in active women, a crossover randomized study

Abstract

The extended endocannabinoid system, also termed endocannabinoidome, participates in multiple metabolic functions in health and disease. Physical activity can both have an acute and chronic impact on endocannabinoid mediators, as does diet. In this crossover randomized controlled study, we investigated the influence of diet on the peripheral response to acute maximal aerobic exercise in a sample of active adult women (n = 7) with no underlying metabolic conditions. We compared the impact of 7-day standardized Mediterranean diet (MedDiet) and control diet inspired by Canadian macronutrient intake (CanDiet) on endocannabinoidome and short-chain fatty acid metabolites post maximal aerobic exercise. Overall, plasmatic endocannabinoids, their congeners and some polyunsaturated fatty acids increased significantly post maximal aerobic exercise upon cessation of exercise and recovered their initial values within 1 h after exercise. Most N-acylethanolamines and polyunsaturated fatty acids increased directly after exercise when the participants had consumed the MedDiet, but not when they had consumed the CanDiet. This impact was different for monoacylglycerol endocannabinoid congeners, which in most cases reacted similarly to acute exercise while on the MedDiet or the CanDiet. Fecal microbiota was only minimally affected by the diet in this cohort. This study demonstrates that endocannabinoidome mediators respond to acute maximal aerobic exercise in a way that is dependent on the diet consumed in the week prior to exercise.

Introduction

The endocannabinoid system (ECS) is deeply involved in multiple metabolic functions in health and disease, as well as in the adaptation to acute/physiological or chronic/pathological deviations from a healthy and active lifestyle. The endocannabinoidome (eCBome) is defined as the expanded ECS1, 2 and is composed of a spectrum of endogenous bioactive lipids, i.e. the endocannabinoids anandamide (AEA) and 2-arachidonoyl-glycerol (2-AG), their congeners and their analogues, the receptors they bind to, and their biosynthetic and catabolic enzymes3,4,5. This system influences daily biological processes such as appetite/feeding, inflammation, stress, neurogenesis, motor activity/coordination, addiction, brain reward system4, 6, 7, depression/mood1, 5, 8,9,10 and circadian cycle11. The ECS is also a central contributor to exercise-related analgesia, sedation (post-exercise calm), anxiolysis and sense of well-being during running exertion6, 8, 12.

Beyond the simple action of exercising, the nature, intensity, frequency and duration of exercise can affect the plasmatic concentrations of eCBs and congeners13,14,15,16,17. It has been suggested that AEA levels are exercise-intensity dependent13 while 2-AG would be less responsive to exercise14, or showed inconsistent modulation between studies18. Additionally, although sex is one of the many factors affecting the eCBome and, as such, must be considered in studies among animals and humans19, only few studies were dedicated to investigate alterations in the female eCBome exclusively during physical activity20, 21. Among adult women, AEA, OEA and 2-AG peripheral levels evolve with acute aerobic exercise depending on the intensity, the degree of habitual exercise and, possibly, the fitness level through adaptive mechanism22.

On top of physical activity6, 22, the diet is a non-negligible environmental factor affecting eCB signalling, with nutrients and energy intake being correlated to the eCBome1, 23, 24. For instance, the increase of some eCBome mediators after a 3-day Mediterranean-inspired dietary intervention was associated to total intake of fatty acids, especially of the omega-3 type (n-3)23. Compared to western diets, the Mediterranean diet is characterized, among others, by increased docosahexaenoic acid (DHA) intake and associated with changes in gut microbiota structure and eCBome mediator levels25. Microbiota-mediated Mediterranean diet effects were proven to attenuate systemic inflammation26 and to protect from cardiometabolic complications27. The differences between the dietary regimens of the general population and athletes, in terms of energy, carbohydrates, fats and proteins, are notable and influence the compositional diversity of gut microbiota1, 2, 28. The impact of exercise and diet on the eCBome could thus be affected by the gut microbiota.

In this study, we focused on healthy active adult women, a demographic that is not extensively described in the literature, due to the common and premature discontinuation of sports among women20, 21. Our main objective was to determine the response of circulating eCBome mediators and short-chain fatty acids (SCFAs) to acute maximal aerobic exercise after 7 days of eating a Mediterranean-style diet (MedDiet) rich in n-3 fatty acids compared to a control diet reflecting average Canadian macronutrient intakes (CanDiet). We also verified the impact of the diet on gut microbiota composition to control, if required, for the potential relationship between the microbiome, diet, exercise and plasmatic eCBome mediators. We hypothesized that the dietary status of active women influences the change in eCBome mediators after an acute bout of maximal aerobic exercise, particularly NAEs13, 14, 16, 22, a class of lipid mediators that is emerging as being influenced by both the diet and gut microbiota composition1, 2, 28.

Material and methods

Ethics

This randomized, crossover and controlled feeding study was conducted at the Institute of Nutrition and Functional Foods (INAF) in Quebec City, Canada. Written informed consent was obtained at the initiation visit. The project was approved by Université Laval Ethics Committee (2019-005) and registered in the ClinicalTrials.gov registry (NCT04766528, 23/02/2021). All experiments were performed in accordance with relevant guidelines and regulations.

Study participants

Candidates that were practising at least three hours of moderate to vigorous physical activity per week, including an hour of running for the last 3 months, and had no signs of cardiometabolic and enteric disorders were admissible. Women who were pregnant, breastfeeding and/or in menopause, smoking, exceeding seven alcoholic beverages per week, had chronic disease, had taken antibiotics in the last 3 months29 or experienced an important weight change (± 5 kg) in the past 6 months could not take part in the study. Physical activity readiness based on cardiovascular health and musculoskeletal function was assessed with the Canadian Society for exercise physiology questionnaires and part of the eligibility conditions30. Twelve active women of 19 to 32 years old were recruited by a research assistant in September 2019 and seven participants completed the study successfully (Table 1). Participants were removed from the study for the following reasons: antibiotics in the week before study (2), antibiotics during study (1), no longer available (1), important delays between aerobic exercise test and blood sampling (1).

Table 1 Initial characteristics of subjects (n = 7).

Study design

Design of the study is summarized in Fig. 1. Participants were randomized (simple randomization) to two treatment sequences (MedDiet first followed by CanDiet, or vice versa) using a computer-generated list. Final sequence assignment was 4 CanDiet-MedDiet and 3 MedDiet-CanDiet. Thus, analyses include 7 participants for which response to CanDiet and MedDiet are compared. Participants had to come to INAF for an initiation visit. They also had to complete web-based self-administered questionnaires31,32,33,34. Afterwards, they received a 7-day MedDiet or 7-day CanDiet. All food and caloric beverages were provided to participants in the form of three meals based on a 7-day menu. After the first dietary intervention, participants underwent a 3-week stabilization period returning to their usual diet. In addition, this duration was selected to increase the probability that participants performed the second dietary intervention in the same menstrual cycle phase as the first dietary intervention. This 3-week stabilization period was coherent with the 28 days average cycle length of participants and use of oral contraceptives in 5 out of 7 participants. Thereafter, participants received 7-day of the diet they did not receive first. Acute maximal aerobic tests were performed at the end of every dietary intervention. The total duration of the study was 35 days (October 10 to November 14, 2019). Throughout the study, participants were asked to maintain their usual level of physical activity.

Figure 1
figure 1

Schematic representation of the randomized crossover format of the study and the process from the start to the end including the periods of restricted diet, aerobic tests, samples taken and analyses performed.

Initiation visit

At the initiation visit, participants were 12 h-fasted, 48 h alcohol-abstinent and had followed their usual physical activity load. Blood samples were collected to evaluate lipid, glycemic and hormonal profiles to confirm participants did not have pathological conditions (data not shown). Weight was measured to the nearest 0.1 kg on a calibrated balance and height was measured to the nearest millimetre with a stadiometer. Body mass index (BMI) was then calculated (kg/m2). Waist circumference measured twice to the nearest millimetre by a standardized procedure at the iliac crest. Throughout the dietary intervention, the body mass was measured regularly and caloric needs were respected to ensure that the weight remained stable35,36,37.

Dietary interventions

The MedDiet provided to the participants was formulated based on characteristics of the traditional Mediterranean eating pattern, including high levels of fibres, micronutrients and plant-based proteins (Table 2). The diet was rich in monounsaturated fatty acids (MUFAs) and n-3 polyunsaturated fatty acids (PUFAs). The control diet (CanDiet) was a Western-style diet designed to reflect current Canadian macronutrient intakes while not causing short-term nutritional deficiencies. The CanDiet was low in fibre and had a high content of saturated fatty acids (SFAs) and simple sugars. Both experimental diets were based on a 7-day menu developed using the Nutrition Data System for Research software (version 2011, Nutrition Coordinating Center, University of Minnesota) and used in previous studies by our group38. Participants were told to consume all and only what was provided. As an exception, they were allowed to consume caffeine-containing drinks with a limit two cups/day. Food consumption was validated using a checklist provided to all participants to identify the prescribed foods that had truly been consumed when eating the diets. This list also provided space to indicate unlisted food items that had been consumed in addition to the formulated diets if applicable.

Table 2 Macronutrients and micronutrients composition of the CanDiet and the MedDiet.

Acute maximal aerobic exercise test

The acute maximal aerobic exercise test involved the completion of two maximal aerobic exercise tests of 10 to 20 min on an indoor track. We used the progressive and continuous aerobic test protocol VAM-EVAL to directly measure aerobic maximal speed and estimate the maximal O2 consumption (VO2max, ml/min/kg), i.e. aerobic capacity, of the participants39. The participants started the test at a pace of 7 km/hour on a marker and ran through the next marker at a 20 m distance. The pace was prescribed by audio recording, increasing by 0.5 km/h every minute. The participants were asked to continue running until volitional exhaustion or were stopped by the experimenter when they missed 2 successive markers. We used CR10 Borg Scale to ensure they had reached a high physical intensity of 8/10 at least (Borg, 1982). Participants executed the two tests at the same time of the day at the two visits to limit intraindividual lipid mediator fluctuations due to circadian fluctuations11.

Blood and fecal sampling

Two certified nurses supervised blood sampling as well as participants’ clinical wellbeing in collaboration with the kinesiologists. One brachial blood extraction pretest (Tpre) was made. With the help of a catheter, the first post-exercise sampling was taken at the nearest time point at the end of the aerobic challenge, corresponding to T0 and the others 15 (T15), 30 (T30), 45 (T45) and 60 (T60) min later. The fecal collection was carried out the day prior to each aerobic maximal test and immediately frozen by the participant.

Plasma endocannabinoids, congeners and fatty acids quantification

Levels of NAEs, MAGs and PUFAs in plasma samples (300 μL) were measured using high-performance liquid chromatography coupled to tandem mass spectrometry (LC–MS/MS)40. It allowed the quantification of NAEs including anandamide (AEA), palmitoyl-ethanolamine (PEA), oleoyl-ethanolamine (OEA), N­linoleoyl-ethanolamine (LEA), N­stearoyl-ethanolamine (SEA), N­docosapentaenoyl‑ethanolamine (DPEA), N­eicosapentaenoyl-ethanolamine (EPEA) and N­docosahexaenoyl‑ethanolamine (DHEA), as well as MAGs including 1/2-arachidonoyl-glycerol (AG), 1/2-palmitoyl-glycerol (PG), 1/2-oleoyl-glycerol (OG), 1/2-linoleoyl-glycerol (LG), 1/2-eicosapentaenoyl-glycerol (EPG), 1/2-docosaepentaenoic-glycerol (DPG) and 1/2-docosahexaenoyl-glycerol (DHG). Monoacylglycerol isomers at positions 1 and 2 can be differentiated using this method. However, given their rapid interconversion and the preferential esterification of PUFA on the sn-2 position of phospholipids, MAGs quantified in this study were summed and identified as 2-MAGs. Unesterified PUFAs, including arachidonic acid (AA), docosahexaenoic acid (DHA), docosapentaenoic acid (DPA) and eicosapentaenoic acid (EPA), were also measured.

Plasma short chain fatty acids quantification

Plasma samples were collected and kept at − 80 °C until SCFA extraction and measurement by gas chromatography. After 2 min centrifugation at 18,000g at 4 °C, 2 aliquots of plasma were acidified with H3PO4 10% to obtain a pH around 2, and deproteinized with 5% v/v of sulfosalicylic acid 500 mg/mL. Samples were then centrifuged 5 min at 18,000g at 4 °C, and supernatants were transferred to a glass vial. An equal volume of methyl tert-butyl ether was added to extract SCFAs by vortexing 2 min. Extracts were centrifuged at 5500g for 10 min at 4 °C to separate organic and aqueous phases. SCFA analysis was performed on a GC-FID system (Shimadzu), consisting of a GC 2010 Plus gas chromatograph equipped with an AOC-20s auto-sampler, an AOC-20i auto-injector and a flame ionization detector. The system was controlled by GC solution software. Two microlitres of organic phase were injected in a split mode into a Nukol capillary GC column (30 m × 0.25 mm id, 0.25 µM film thickness, Supelco analytical) and hydrogen was used as carrier gas. The injector and detector were set at 250 °C. The oven temperature was initially programmed at 60 °C, then increased to 200 °C at 12 °C/min, which was held 7 min. SCFA were quantified using a 5-point calibration curve prepared with a mix of standards (acetic acid, propionic acid, butyric acid, isobutyric acid and valeric acid) extracted following the same procedure as plasma samples.

Stool collection and metataxonomic analysis

Stool microbial DNA was extracted using the QIAamp DNA Stool Mini Kit (QIAGEN, CA, USA)23. Amplification of the 16S ribosomal RNA region V3-V4 was performed using the forward primer S-D-Bact-0341-b-S-17 (5=CCTACGGGNGGCWGCAG) and reverse primer S-D-Bact-0785-a-A-21 (5=GACTACHVGGGTATCTAATCC)41 concatenated with the Illumina adapters used for the Nextera library prep kits (Illumina, CA, USA). Briefly, each library was amplified in a total volume of 20 µL that contained 0.25 µM of each primer, 10 µL of 2X Phusion High-Fidelity PCR Master Mix (Thermo Scientific, Vilnius, Lithuania) and 1 µL of microbial DNA. The PCR started with an initial denaturation at 98 °C for 2 min followed by 35 cycles of denaturation at 98 °C for 10 s, annealing at 55 °C for 30 s, extension at 72 °C for 30 s followed by a final extension step at 72 °C for 2 min. PCR reactions were diluted to a fifth and used as a template for barcoding PCR. Second PCR was done in a total volume of 10 µL with 0.5 µL of each dual-index primer from the Nextera XT DNA Library Prep Kit (Illumina, CA, USA), 1 µL of the diluted cDNA template, 3 µL of UltraPure DNase/RNase-Free Distilled Water and 5 µL of 2X Phusion High-Fidelity PCR Master Mix (Thermo Scientific, Mississauga, Canada). The second cycle used the same cycling parameters, but with eight cycles. Barcoded Amplicons were then pooled in equimolar concentration and purified using AMPure XP beads (Brea, CA, USA). Libraries were sequenced on the Illumina Miseq.

Raw sequences were demultiplexed following the Illumina default parameters. Raw sequencing reads are available in SRA (PRJNA758983). Sequence assignation to amplicon sequence variants (ASV) was done in R version 3.1.2 using Dada2 package version 1.5.042. Primer sequences were removed using cutadapt 3.2. Sequences were trimmed at 270 pb for forward reads and 210 pb for reverse reads. Amplicon error learning for the forward and reverse reads was performed on 100 M nucleotides using the DADA2 algorithm with default parameters. Denoised output reads were generated by dereplication and all reads with any mismatches were removed. Forward and reverse reads were merged, and chimera sequences were removed with the uchime_denovo function from vsearch package with a minimum difference set at 2. Purged ASV sequences with more than 4 read counts were kept. ASV assignation to bacterial taxa was performed by alignment based on the silva database version 13843. Finally, samples have been rarefied at 13 827 reads per sample. Statistical analyses were only performed on OTU that were at more than 1% in at least one sample.

Statistical methods

All figures and statistical analyses were generated using R studio software. Mixed linear-effect models (LME) including random individual effect was used to identify metabolites influenced by diet, the time of sampling and the interaction between these two factors. The primary objective was to determine if plasma lipid mediators were differentially modulated after exercise following different dietary interventions. Plasma lipid concentrations have been normalized using ranked values fitted into LME (~ diet * time) and significance has been tested by analysis of variance (ANOVA) with random effects nested within participants. A p-value lower than 0.05 was considered significant. The secondary objective was to determine if microbiome composition was differentially modulated following dietary interventions. A fixed effect linear model (~ diet) was used to test the influence of diet on the microbiota families. A p-value lower than 0.05 was considered significant. Principal component analysis (PCA) and multiple factor analysis (MFA) were made using the ‘FactoMineR' package. PCA and MFA plots were made with fviz_pca and fviz_mfa functions of the 'factoextra' package. Metabolite response plots and microbiota families dot plots were drawn with the ‘ggplot2’ package. Permutational multivariate analysis of variance (PERMANOVA) has been made using adonis function of the ‘vegan’ package with a number of permutations of 100,000. Hierarchical clustering of microbiome samples were based on Canberra distance. Barplots were drawn with barplot2 function from the ‘gplots’ package.

Results

Active female participants were recruited for this randomized crossover study to assess the impact of diet on eCBome mediators response post maximal aerobic exercise. Overall, participants had BMI and waist circumference averages representing a healthy body weight (Table 1). The mean estimated VO2max of participants was categorized as “sportive” for 20–29 year old individuals (Table 3)44. Likewise, the average heart rate at 5-min post-test was slightly below the 101–102 bpm of healthy subjects after a short treadmill exercise test reported in previous studies45, 46. The estimated VO2 max and the max heart rate were similar in both tests thus confirming that the intensity and effort were similar between diet interventions.

Table 3 Aerobic measurements after CanDiet and MedDiet.

Plasma N-acyl-ethanolamines post-exercise response differs between diets

Plasma N-acyl-ethanolamines (NAEs) showed post-exercise profiles dependent on the diet (Fig. 2A). Before exercise, only OEA was significantly increased by the MedDiet compared to CanDiet. This mediator remained significantly higher with MedDiet compared to CanDiet at several time points. DPEA, DHEA and LEA had similar response curves between the two diets. Statistically significant increases at T0, i.e. immediately after exercise, were observed following the MedDiet for AEA and LEA. No significant increase at T0 was observed for OEA, PEA and SEA following the MedDiet and for all NAEs following the CanDiet.

Figure 2
figure 2

Response curves of eCBome mediators and precursors (fmol/μl) to maximal aerobic test according to the diet. Panels show results for (A) N-acylethanolamines, (B) monoacylglycerols and (C) polyunsaturated fatty acids. The graph represents the mean with the standard error of the plasmatic concentrations of these lipids at each time point for the two diets. Tpre corresponds to the initial concentration before the aerobic test, T0 corresponds to the immediate end of the aerobic test and T15, T30, T45 and T60 correspond to the recovery phase. Lipid concentrations have been normalized using ranked values fitted into mixed linear-effect models (LME) and differences between diets and times have been tested by analysis of variance (ANOVA). For difference between diets, significance was set at p < 0.1 (.), p < 0.05 (*), p < 0.01 (**) and p < 0.001 (***). For difference between times, indicated by bold blue line, significance was set at p < 0.1 (a), p < 0.05 (b), p < 0.01 (c), p < 0.001 (d). N = 7 per diet. Names of the molecules are anandamide (AEA), N-palmitoylethanolamine (PEA), N-oleoylethanolamine (OEA), N­linoleoylethanolamine (LEA), N-stearoylethanolamine (SEA), N­docosapentaenoylethanolamine (DPEA), N­eicosapentaenoylethanolamine (EPEA), N­docosahexaenoyl‑ethanolamine (DHEA), 1- plus 2-arachidonoyl-glycerol (2-AG), 1- plus 2-palmitoyl-glycerol (2-PG), 1- plus 2-oleoyl-glycerol (2-OG), linoleoyl-glycerol (2-LG), 1- plus 2-eicosapentaenoyl-glycerol (2-EPG), 1- plus 2-docosaepentaenoic-glycerol (2-DPG), 1- plus 2-docosahexaenoyl-glycerol (2-DHG), arachidonic acid (AA), docosahexaenoic acid (DHA), docosapentaenoic acid (DPA) and eicosapentaenoic acid (EPA).

Plasma 2-monoacylglycerol post exercise profiles were similar between diets

In general, plasmatic 2-monoacylglycerols (2-MAGs) reacted similarly to acute maximal aerobic exercise after the MedDiet and CanDiet (Fig. 2B). However, before exercise, 2-OG and 2-EPG were significantly higher with the MedDiet than with the CanDiet at Tpre. Peaks at T0 after exercise were observed for 2-AG and 2-LG in both diets. Most 2-MAG concentrations decreased significantly as soon as 15 min after exercise. After CanDiet, most 2-MAGs, excluding 2-DHG and 2-DPG, had similar concentrations at Tpre and T60, which suggests a return to basal levels after exercise. After the MedDiet, 2-MAGs had lower concentrations after 60 min recovery (T60) than their initial value (Tpre).

Plasma PUFA post exercise response was diet dependent

Plasma concentrations of PUFAs before acute maximal aerobic exercise were significantly higher with the MedDiet compared to the CanDiet, except for arachidonic acid (AA) (Fig. 2C). For all time points, both before and after exercise, average PUFA levels were higher with the MedDiet than the CanDiet. Plasma PUFA levels peaked at T0 post exercise, remained high 15 min and returned to their initial levels at T60 only when participants consumed the MedDiet. When participants consumed the CanDiet, plasma fatty acid composition remained stable through time and only marginal changes in relation to exercise were observed for the n-3 PUFAs.

Plasmatic SCFA post exercise response was similar between diets

We quantified plasma levels of SCFAs in response to acute maximal aerobic exercise and diets (Fig. 3). Acetic acid had significantly higher concentration with the MedDiet compared to the CanDiet at Tpre. On the contrary, isovaleric acid concentration was significantly higher with the CanDiet compared to the MedDiet before exercise, but its levels dropped after exercise at T0. The acetic acid curve had a similar shape between the two dietary interventions, with concentrations that remained significantly superior in the MedDiet compared with the CanDiet throughout the protocol. The isobutyric acid response was nearly identical between the two diets, with a strong peak at T0 with MedDiet and CanDiet and a gradual return to initial level at later time points. Other SCFAs presented modest reactivity to acute maximal aerobic exercise in either MedDiet or CanDiet.

Figure 3
figure 3

Response curves of SCFA to maximal aerobic test according to the diet. The graph represents the means with the standard errors of the plasmatic SCFA concentrations at each time point for the two diets. Tpre corresponds to the initial concentration before the aerobic test, T0 corresponds to the immediate end of the aerobic test and T15, T30, T45 and T60 correspond to the recovery phase. SCFA concentrations have been normalized using ranked values fitted into mixed linear-effect models (LME) and differences between diets and times have been tested by analysis of variance (ANOVA). For difference between diets, significance was set at p < 0.1 (.), p < 0.05 (*), p < 0.01 (**) and p < 0.001 (***). For difference between times, indicated by bold blue line, significance was set at p < 0.1 (a), p < 0.05 (b), p < 0.01 (c), p < 0.001 (d). N = 7 per diet.

Overview of eCBome and SCFA post exercise response between diets

We used a principal component analysis (PCA) to represent all plasmatic mediators together, including NAEs, MAGs, PUFAs and SCFAs (Fig. 4). The difference between MedDiet and CanDiet was significant (Fig. 4A), supporting the concept that the diet influences the response to exercise of eCBome mediators and/or bioactive gut microbiota metabolites such as SCFA (p = 0.004**, PERMANOVA). The PCA showed differences between MedDiet and CanDiet in plasma metabolite levels at baseline (Tpre), immediately after exercise (T0) and at later recovery time points (Fig. 4B). However, we observed an overlap of the samples at 15, 30, 45 and 60 min after the exercise. The order in which participants received the diets had no effect on the lipid profile (Fig. 4C). Variable contribution to PCA dimensions indicates associations between NAE and PUFA levels with diets (Fig. 4D). 2-MAGs and SCFAs were generally associated with time.

Figure 4
figure 4

Representation of plasmatic lipid mediators and SCFA profiles shows an effect of diet and time post-exercise on the endocannabinoidome. Principal component analysis (PCA) of plasmatic profiles of free n-3 PUFA, endocannabinoids and endocannabinoid-like mediators and SCFA, where ellipses show how these metabolites differentiate (A) diet, (B) time points and (C) visits. (D) Loading plot shows the influence of plasmatic lipids on the PCA plot. P-values on PCA were obtained by permutational multivariate analysis of variance (PERMANOVA).

Standardized diets had limited impact on active women fecal microbiota

We determined fecal microbiota composition at the end of each dietary intervention, prior to acute maximal aerobic exercise test. Fecal microbiota composition was modestly affected by 1-week dietary intervention with the MedDiet or CanDiet (Fig. 5A). The order of the diets in the crossover design did not affect microbiota composition (Fig. 5B). Variables associated to the axes of the multiple factor analysis (MFA) are shown in Fig. 5C. Interindividual variability was the main factor explaining the differences between microbiota composition as hierarchical clustering of participants indicated that it had a greater impact than 1-week dietary intervention (Fig. 5D). Four bacterial families were, however, differentially modulated by the MedDiet and CanDiet. Oscillospiraceae and Prevotellaceae were significantly higher in the MedDiet compared to the CanDiet, whereas Coriobacteriaceae and Erysipelotrichaceae were significantly lower (Fig. 5E).

Figure 5
figure 5

Multiple factor analysis (MFA) of the gut microbiota profile. Ellipses show the effect of (A) diet and (B) visit on individuals at different time points. (C) Loading plot shows the influence of the top 30 microbiota taxa with the highest contribution on the MFA plot. P-values on MFA were obtained by permutational multivariate analysis of variance (PERMANOVA). (D) Barplot representing the relative abundance of the 18 more abundant gut microbiota’s families. Dendrogram showing hierarchical clustering on Canberra distance between samples is printed above the barplot and determines the sample order. (E) Relative abundance of bacterial families significantly different between diet. Relative abundance of microbiota taxa has been normalized using ranked values fitted into mixed linear-effect models (LME) and differences between diets have been tested by analysis of variance (ANOVA). Significance was set at p < 0.1 (.), p < 0.05 (*), p < 0.01 (**) and p < 0.001 (***).

Discussion and conclusions

The objective of this study was to determine if diet composition influenced the acute response post maximal exercise of circulating eCBome mediators and SCFAs in a sample of active women with no underlying metabolic conditions. Overall, our observations suggested that plasma eCBs, their congeners and some PUFAs, which are both ultimate biosynthetic precursors and metabolic products of these mediators, exhibit higher concentrations at the cessation of exercise. However, not all eCBome mediators reacted similarly, even when they belonged to the same family. The diet had a strong influence on many molecules, especially some NAEs and PUFAs, while other metabolites, including SCFAs, did not seem to be affected by the diet in the present study. Most NAEs and PUFAs increased after exercise when the participants consumed the MedDiet, but not when they ate the CanDiet. This relationship was different for 2-MAGs, which in most cases reacted similarly post-exercise with either the MedDiet or the CanDiet. Considering that fecal gut microbiota was modestly altered by the diet, the investigation of the interaction between diet, gut microbiota, eCBome and exercise were limited in this study.

This study showed that several plasmatic eCBs, eCB-like molecules and PUFAs had higher concentration at the end of aerobic exercise during MedDiet. For many of these metabolites, concentrations returned to baseline levels during the recovery phase. Previous work among heterogeneous populations globally showed that NAEs significantly increased upon 30 min of exercise of moderate intensity or over in a short-term manner13, 14, 22, 47. Interestingly, NAEs levels were also enhanced with a longer aerobic demand lasting up to 5 h in hypoxic conditions15. Some investigators have shown that AEA and OEA increased after 20 min of moderate exercise, while 2-AG, PEA and 2-OG remained stable for adult women reporting major depressive disorder48. The same conclusion was made among women of 27 to 43 years-of-age, where AEA and OEA increase was associated to moderate-vigorous daily exercise49. Therefore, it was not surprising that AEA and OEA were both responsive to aerobic exercise of maximal intensity in the present study, also considering that they share similar metabolic pathways50. However, Crombie and colleagues (2018) documented that not only AEA, OEA, but also 2-AG concentrations greatly increased following 30 min of moderate running in healthy adults, females in majority51. The increase of AEA levels after aerobic exercise could be due to the decrease of the major AEA degradation enzyme (fatty acid amide hydrolase) as shown in a middle-aged female cohort52. Conversely, another study in healthy people found that the long-term impact of exercise intervention was to reduce plasma AEA concentration53. After 30 min of arm cycling at a steady pace and incremental load, plasma levels of OEA, PEA, SEA and 2-AG were similar to levels prior to exercise after 60 min recovery, while AEA levels were slightly lower after recovery54, which supports the short-lasting effect of exercise on eCBome mediators. While incongruences in intervention and inclusion criteria are existent in the cited studies, these past results are coherent with the observations of the current study. However, previous studies in humans on the effect of exercise on plasma eCBs and eCB congener-like mediators did not consider the possible role of underlying dietary habits, which may also account for, or contribute to, the often slight but nevertheless important differences in the outcomes of such studies.

Indeed, we found that the diet influences the concentrations of specific eCBome mediators before and after aerobic exercise. A recent and similarly designed (but exercise-unrelated) study showed that the intake of EPA, DHA55, arachidonic acid (AA) and oleic acid (OA) was correlated to greater levels of plasma n-3 fatty acid- or OA-derived mediators23. The higher proportions of dietary and available PUFAs, MUFAs, OA, EPA, DPA and DHA in the MedDiet compared to the CanDiet could have contributed to the increase of n-3, n-6 and n-6 PUFA-derived NAE levels for participants under MedDiet. An additional explanation to the enhancer effect of the MedDiet on NAE and PUFA levels with exercise could be its modulation of muscle-specific eCB enzyme expression by both the diet56 and training50 observed in lean and obese subjects. Dietary fat intake was also associated to CB1 expression level reduction in the skeletal muscle in humans and rats47, 56 and could likewise explain the weaker alteration of eCB levels with exercise in CanDiet compared to MedDiet.

The alterations by either the diet or exercise, or both, of the plasma concentrations of eCBome mediators are likely to have functional consequences1, 8, 57. These molecules have several molecular targets among G protein-coupled receptors, ligand-activated ion channels and nuclear receptors, which have been implicated to different degrees in the metabolic and mood effects of food intake and exercise. In particular, although it is not possible to infer central actions from circulating endocannabinoid levels, CB1 receptor activation by AEA and 2-AG after the MedDiet immediately following the onset of exercise might induce anxiolytic and antidepressant action in response to stress, thus contributing to the runners “high”, and at the same time favouring food intake to replenish fuel exhausted because of exercise8. By contrast, in non-metabolically healthy people, CB1 activation in the periphery may contribute to energy accumulation and to chronic low-grade inflammation1. The decrease of eCBs during the process of recovery after exercise, in one or both diets, might be required to enhance the mobilization of energy necessary for physical exercise and its recovery. The elevated levels of the PPARα agonist OEA following the MedDiet and throughout the duration of exercise might allow for enhanced lipogenesis and fatty acid oxidation, again necessary for energy expenditure. For CanDiet individuals, this role might be played instead by 1/2-PG, another PPARα agonist58, whose levels remained higher at later times following the onset of exercise in these subjects. Stimulation by exercise of LEA and 1/2-LG levels, by activating GPR119, a glucagon-like peptide-1 releasing receptor in L cells of the intestinal epithelium, or transient receptor potential vanilloid type-1 channels in pancreatic β-cells, might contribute to counterbalancing CB1 activation, notably in terms of regulating insulin release and sensitivity50, 59. Finally, the overall increased levels of EPEA and 1/2-EPG, two potential anti-inflammatory mediators, with the MedDiet might confer to individuals under such dietary condition resistance to exercise stress-induced inflammation.

We observed a limited effect of the diet on gut microbiota composition. This was not entirely surprising as individuals who are used to carry out sport are known to harbour a more stable gut microbiota with improved metabolic functions than sedentary individuals60. The structural diversity and stability of the participants’ baseline gut microbiota could explain the modest impact of the diet on gut microbiota composition61. The effect of the dietary intervention on circulating SCFAs was also limited, as only acetic acid and isovaleric acid were significantly increased and decreased, respectively, in the MedDiet before aerobic exercise. Minimal microbiota modulation by the diets could explain why little changes in SFCA levels post exercise were observed between diets. Indeed, bacteria associated with butyrate production, for example Lachnospiraceae and Ruminococcaceae62,63,64, already had a high relative abundance in participants before intervention and their levels did not vary significantly between the diets. Nevertheless, contrasting modulation of acetate and isovalerate in response to diet and exercise might indicate that even minimal diet-induced changes in the gut microbiota of healthy lifestyle young healthy individuals may have functional importance, as acetate is considered beneficial and isovalerate detrimental for metabolic health65. In past studies, SCFA levels in feces were related to diet and an active lifestyle66,67,68,69,70. Previous studies mostly assessed fecal concentrations after exercise60, 63, or in cohorts of athletes compared to controls71. Additional studies suggested that propionic acid and butyric acid increased with exercise72,73,74,75. Our findings provide new insight on SCFA modulation by maximal exercise.

In summary, this study investigated the response to acute maximal aerobic test of an extensive array of eCBome mediators, covering NAEs, MAGs, and some of their corresponding free fatty acids. It also provided profiles for acute SCFA levels in plasma following exercise. A clear limitation of our study is the small size of the cohort sampled. However, we overcame this limitation by using a randomized crossover design, which allowed participants to act as their own controls. Additionally, we submitted the participants to stringent admissibility criteria and to a controlled full-feeding program prior to the acute maximal aerobic test, which minimized many transient and permanent confounding variables that could have affected the results. These strategies helped to compensate for the potential problems arising from the use of a small sample of participants and allowed to observe statistically significant alterations by either diet, exercise, or both. An important strength of the study is the selection of a homogenous population characterized by women living an active lifestyle. This cohort enabled to distinguish the effect of intense physical activity from extreme homeostatic stress, which unfit individuals would have faced. Overall, our study shows that eCBome mediators react to acute exercise in a way that is dependent on the diet consumed in the week prior to exercise.

Data availability

Raw sequencing reads are available in SRA (PRJNA758983).

References

  1. Di Marzo, V. & Silvestri, C. Lifestyle and metabolic syndrome: Contribution of the endocannabinoidome. Nutrients 11, 1956 (2019).

    CAS  PubMed Central  Article  Google Scholar 

  2. Manca, C. et al. Germ-free mice exhibit profound gut microbiota-dependent alterations of intestinal endocannabinoidome signaling. J. Lipid Res. 61, 70–85 (2020).

    CAS  PubMed  Article  Google Scholar 

  3. Fezza, F. et al. Endocannabinoids, related compounds and their metabolic routes. Molecules 19, 17078–17106 (2014).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  4. Di Marzo, V. New approaches and challenges to targeting the endocannabinoid system. Nat. Rev. Drug Discovery 17, 623–639 (2018).

    PubMed  Article  CAS  Google Scholar 

  5. Di Marzo, V., Stella, N. & Zimmer, A. Endocannabinoid signalling and the deteriorating brain. Nat. Rev. Neurosci. 16, 30–42 (2015).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  6. Dietrich, A. Endocannabinoids and exercise. Br. J. Sports Med. 38, 536–541 (2004).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  7. Cani, P. D. et al. Endocannabinoids—at the crossroads between the gut microbiota and host metabolism. Nat. Rev. Endocrinol. 12, 133–143 (2016).

    CAS  PubMed  Article  Google Scholar 

  8. Forteza, F., Giorgini, G. & Raymond, F. Neurobiological processes induced by aerobic exercise through the endocannabinoidome. Cells 10, 938 (2021).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  9. Manca, C. et al. Alterations of brain endocannabinoidome signaling in germ-free mice. Biochim. Biophys. Acta Mol. Cell Biol. of Lipids 1865, 158786 (2020).

    CAS  Article  Google Scholar 

  10. Chevalier, G. et al. Effect of gut microbiota on depressive-like behaviors in mice is mediated by the endocannabinoid system. Nat. Commun. 11, 1–15 (2020).

    Article  CAS  Google Scholar 

  11. Hanlon, E. C. et al. Circadian misalignment of the 24-hour profile of endocannabinoid 2-arachidonoylglycerol (2-AG) in obese adults. J. Clin. Endocrinol. Metab. 105, 792–802 (2020).

    PubMed Central  Article  Google Scholar 

  12. Raichlen, D. A., Foster, A. D., Gerdeman, G. L., Seillier, A. & Giuffrida, A. Wired to run: Exercise-induced endocannabinoid signaling in humans and cursorial mammals with implications for the ‘runner’s high’. J. Exp. Biol. 215, 1331–1336 (2012).

    CAS  PubMed  Article  Google Scholar 

  13. Raichlen, D. A., Foster, A. D., Seillier, A., Giuffrida, A. & Gerdeman, G. L. Exercise-induced endocannabinoid signaling is modulated by intensity. Eur. J. Appl. Physiol. 113, 869–875 (2013).

    CAS  PubMed  Article  Google Scholar 

  14. Heyman, E. et al. Intense exercise increases circulating endocannabinoid and BDNF levels in humans—Possible implications for reward and depression. Psychoneuroendocrinology 37, 844–851 (2012).

    CAS  PubMed  Article  Google Scholar 

  15. Feuerecker, M. et al. Effects of exercise stress on the endocannabinoid system in humans under field conditions. Eur. J. Appl. Physiol. 112, 2777–2781 (2012).

    CAS  PubMed  Article  Google Scholar 

  16. Sparling, P. B., Giuffrida, A., Piomelli, D., Rosskopf, L. & Dietrich, A. Exercise activates the endocannabinoid system. NeuroReport 14, 2209–2211 (2003).

    CAS  PubMed  Article  Google Scholar 

  17. Hicks, S. D. et al. The transcriptional signature of a runner’s high. Med. Sci. Sports Exerc. 51, 970–978. https://doi.org/10.1249/MSS.0000000000001865 (2019).

    CAS  Article  PubMed  Google Scholar 

  18. Desai, S. et al. A systematic review and meta-analysis on the effects of exercise on the endocannabinoid system. Cannabis Cannabinoid Res. https://doi.org/10.1089/can.2021.0113 (2021).

    Article  PubMed  Google Scholar 

  19. Thompson, Z., Argueta, D., Garland, T. & DiPatrizio, N. Circulating levels of endocannabinoids respond acutely to voluntary exercise, are altered in mice selectively bred for high voluntary wheel running, and differ between the sexes. Physiol. Behav. 170, 141–150 (2017).

    CAS  PubMed  Article  Google Scholar 

  20. Reichert, F. F., Barros, A. J. D., Domingues, M. R. & Hallal, P. C. The role of perceived personal barriers to engagement in leisure-time physical activity. Am. J. Public Health 97, 515–519 (2007).

    PubMed  PubMed Central  Article  Google Scholar 

  21. Kyröläinen, H. et al. Effects of combined strength and endurance training on physical performance and biomarkers of healthy young women. J. Strength Cond. Res. 32, 1554–1561 (2018).

    PubMed  Article  Google Scholar 

  22. Tantimonaco, M. et al. Physical activity and the endocannabinoid system: An overview. Cell. Mol. Life Sci. 71, 2681–2698 (2014).

    CAS  PubMed  Article  Google Scholar 

  23. Castonguay-Paradis, S. et al. Dietary fatty acid intake and gut microbiota determine circulating endocannabinoidome signaling beyond the effect of body fat. Sci. Rep. 10, 1–11 (2020).

    Article  CAS  Google Scholar 

  24. Gamelin, F.-X. et al. Exercise training and high-fat diet elicit endocannabinoid system modifications in the rat hypothalamus and hippocampus. J. Physiol. Biochem. 73, 335–347 (2016).

    PubMed  Article  CAS  Google Scholar 

  25. Baptista, L. C., Sun, Y., Carter, C. S. & Buford, T. W. Crosstalk between the gut microbiome and bioactive lipids: Therapeutic targets in cognitive frailty. Front. Nutr. 7, 17 (2020).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  26. Bailey, M. A. & Holscher, H. D. Microbiome-mediated effects of the mediterranean diet on inflammation. Adv. Nutr. 9, 193–206 (2018).

    PubMed  PubMed Central  Article  Google Scholar 

  27. Agus, A. et al. 90 western diet induces a shift in microbiota composition enhancing susceptibility to adherent-invasive E. coli infection and intestinal inflammation. Gastroenterology 150, S23 (2016).

    Article  Google Scholar 

  28. Lacroix, S. et al. Rapid and concomitant gut microbiota and endocannabinoidome response to diet-induced obesity in mice. mSystems 4, e00407-19 (2019).

    PubMed  PubMed Central  Article  Google Scholar 

  29. Raymond, F., Déraspe, M., Boissinot, M., Bergeron, M. G. & Corbeil, J. Partial recovery of microbiomes after antibiotic treatment. Gut Microbes 7, 428–434 (2016).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  30. Canadian Society for exercise physiology. Get Active questionnaire. (2017).

  31. Lafrenière, J., Lamarche, B., Laramée, C., Robitaille, J. & Lemieux, S. Validation of a newly automated web-based 24-hour dietary recall using fully controlled feeding studies. BMC Nutr. 3, 1–10 (2017).

    Article  Google Scholar 

  32. Lafrenière, J., Laramée, C., Robitaille, J., Lamarche, B. & Lemieux, S. Assessing the relative validity of a new, web-based, self-administered 24 h dietary recall in a French-Canadian population. Public Health Nutr. 21, 2744–2752 (2018).

    PubMed  Article  Google Scholar 

  33. Stewart-Brown, S. et al. The Warwick-Edinburgh Mental Well-being Scale (WEMWBS): A valid and reliable tool for measuring mental well-being in diverse populations and projects. J. Epidemiol. Community Health 65, A38–A39 (2011).

    Article  Google Scholar 

  34. Smith, O. R. F., Alves, D. E., Knapstad, M., Haug, E. & Aarø, L. E. Measuring mental well-being in Norway: Validation of the Warwick-Edinburgh Mental Well-being Scale (WEMWBS). BMC Psychiatry 17, 1–9 (2017).

    CAS  Article  Google Scholar 

  35. Rancourt-Bouchard, M. et al. Effects of regular-fat and low-fat dairy consumption on daytime ambulatory blood pressure and other cardiometabolic risk factors: A randomized controlled feeding trial. Am. J. Clin. Nutr. 111, 42–51 (2020).

    PubMed  Article  Google Scholar 

  36. Bouchard, C. et al. A method to assess energy expenditure in children and adults. Am. J. Clin. Nutr. 37, 461–467 (1983).

    CAS  PubMed  Article  Google Scholar 

  37. Harris, J. A. & Benedict, F. G. A biometric study of human basal metabolism. Proc. Natl. Acad. Sci. USA. 4, 370 (1918).

    ADS  CAS  PubMed  PubMed Central  Article  Google Scholar 

  38. Conway, V. et al. Impact of buttermilk consumption on plasma lipids and surrogate markers of cholesterol homeostasis in men and women. Nutr. Metab. Cardiovasc. Dis. 23, 1255–1262 (2013).

    CAS  PubMed  Article  Google Scholar 

  39. Yang, Y. et al. The association between cardiorespiratory fitness and gut microbiota composition in premenopausal women. Nutrients 9, 792 (2017).

    PubMed Central  Article  CAS  Google Scholar 

  40. Turcotte, C. et al. Endocannabinoid hydrolysis inhibition unmasks that unsaturated fatty acids induce a robust biosynthesis of 2-arachidonoyl-glycerol and its congeners in human myeloid leukocytes. FASEB J. 34, 4253–4265 (2020).

    CAS  PubMed  Article  Google Scholar 

  41. Klindworth, A. et al. Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies. Nucleic Acids Res. 41, e1 (2013).

    CAS  PubMed  Article  Google Scholar 

  42. Callahan, B. J. et al. DADA2: High-resolution sample inference from Illumina amplicon data. Nat. Methods 13, 581–583 (2016).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  43. Quast, C. et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. 7.

  44. Mercier, D., Léger, L. & Desjardins, M. Nomogramme pour prédire la performance, le VO2max et l’endurance relative en course de fond. Médecine du Sport 58, 181–187 (1984).

    Google Scholar 

  45. Bosquet, L., Gamelin, F.-X. & Berthoin, S. Reliability of postexercise heart rate recovery. Int. J. Sports Med. 29, 238–243 (2008).

    CAS  PubMed  Article  Google Scholar 

  46. Tulumen, E. et al. The reproducibility of heart rate recovery after treadmill exercise test: Reproducibility of heart rate recovery. Ann. Noninvasive Electrocardiol. 16, 365–372 (2011).

    PubMed  PubMed Central  Article  Google Scholar 

  47. Ruiz de Azua, I. & Lutz, B. Multiple endocannabinoid-mediated mechanisms in the regulation of energy homeostasis in brain and peripheral tissues. Cell. Mol. Life Sci. 76, 1341–1363 (2019).

    CAS  PubMed  Article  Google Scholar 

  48. Meyer, J. D., Crombie, K. M., Cook, D. B., Hillard, C. J. & Koltyn, K. F. Serum endocannabinoid and mood changes after exercise in major depressive disorder. Med. Sci. Sports Exerc. 51, 1909–1917 (2019).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  49. Fernández-Aranda, F. et al. Moderate-vigorous physical activity across body mass index in females: Moderating effect of endocannabinoids and temperament. PLoS ONE 9, e104534 (2014).

    ADS  PubMed  PubMed Central  Article  CAS  Google Scholar 

  50. Heyman, E., Gamelin, F.-X., Aucouturier, J. & Di Marzo, V. The role of the endocannabinoid system in skeletal muscle and metabolic adaptations to exercise: Potential implications for the treatment of obesity: Exercise and the endocannabinoid system. Obes. Rev. 13, 1110–1124 (2012).

    CAS  PubMed  Article  Google Scholar 

  51. Crombie, K. M., Brellenthin, A. G., Hillard, C. J. & Koltyn, K. F. Psychobiological responses to aerobic exercise in individuals with posttraumatic stress disorder: Psychobiological responses to exercise in PTSD. J. Trauma. Stress 31, 134–145 (2018).

    PubMed  Article  Google Scholar 

  52. You, T., Disanzo, B. L., Wang, X., Yang, R. & Gong, D. Adipose tissue endocannabinoid system gene expression: Depot differences and effects of diet and exercise. Lipids Health Dis. 10, 194 (2011).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  53. Belitardo de Oliveira, A., de Mello, M. T., Tufik, S. & Peres, M. F. P. Weight loss and improved mood after aerobic exercise training are linked to lower plasma anandamide in healthy people. Physiol. Behav. 201, 191–197 (2019).

    CAS  PubMed  Article  Google Scholar 

  54. Stensson, N. & Grimby-Ekman, A. Altered relationship between anandamide and glutamate in circulation after 30 min of arm cycling: A comparison of chronic pain subject with healthy controls. Mol. Pain 15, 174480691989836 (2019).

    Article  CAS  Google Scholar 

  55. Watkins, B. A. Diet, endocannabinoids, and health. Nutr. Res. 70, 32–39 (2019).

    CAS  PubMed  Article  Google Scholar 

  56. Engeli, S. et al. Influence of dietary fat intake on the endocannabinoid system in lean and obese subjects: Endocannabinoids and high-fat diet. Obesity 22, E70–E76 (2014).

    CAS  PubMed  Article  Google Scholar 

  57. Iannotti, F. A. & Di Marzo, V. The gut microbiome, endocannabinoids and metabolic disorders. J. Endocrinol. 248, R83–R97 (2021).

    CAS  PubMed  Article  Google Scholar 

  58. Depommier, C. et al. Beneficial effects of akkermansia muciniphila are not associated with major changes in the circulating endocannabinoidome but linked to higher mono-palmitoyl-glycerol levels as new PPARα agonists. Cells 10, 185 (2021).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  59. Syed, S. K. et al. Regulation of GPR119 receptor activity with endocannabinoid-like lipids. Am. J. Physiol. Endocrinol. Metab. 303, E1469-1478 (2012).

    CAS  PubMed  Article  Google Scholar 

  60. Zhao, X. et al. Response of gut microbiota to metabolite changes induced by endurance exercise. Front. Microbiol. 9, 765 (2018).

    ADS  PubMed  PubMed Central  Article  Google Scholar 

  61. Raymond, F. et al. The initial state of the human gut microbiome determines its reshaping by antibiotics. ISME J. 10, 707–720 (2016).

    CAS  PubMed  Article  Google Scholar 

  62. Allen, J. M. et al. Exercise alters gut microbiota composition and function in lean and obese humans. Med. Sci. Sports Exerc. 50, 747–757 (2018).

    PubMed  Article  Google Scholar 

  63. Matsumoto, M. et al. Voluntary running exercise alters microbiota composition and increases n-butyrate concentration in the rat cecum. Biosci. Biotechnol. Biochem. 72, 572–576 (2008).

    CAS  PubMed  Article  Google Scholar 

  64. Queipo-Ortuño, M. I. et al. Gut microbiota composition in male rat models under different nutritional status and physical activity and its association with serum leptin and ghrelin levels. PLoS ONE 8, e65465 (2013).

    ADS  PubMed  PubMed Central  Article  CAS  Google Scholar 

  65. Mayengbam, S. et al. Impact of dietary fiber supplementation on modulating microbiota–host–metabolic axes in obesity. J. Nutr. Biochem. 64, 228–236 (2019).

    CAS  PubMed  Article  Google Scholar 

  66. Wu, G. D. et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 334, 105–108 (2011).

    ADS  CAS  PubMed  PubMed Central  Article  Google Scholar 

  67. Matt, S. M. et al. Butyrate and dietary soluble fiber improve neuroinflammation associated with aging in mice. Front. Immunol. 9, 1832 (2018).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  68. So, D. et al. Dietary fiber intervention on gut microbiota composition in healthy adults: A systematic review and meta-analysis. Am. J. Clin. Nutr. 107, 965–983 (2018).

    PubMed  Article  Google Scholar 

  69. Morris, G. et al. The role of the microbial metabolites including tryptophan catabolites and short chain fatty acids in the pathophysiology of immune-inflammatory and neuroimmune disease. Mol. Neurobiol. 54, 4432–4451 (2017).

    CAS  PubMed  Article  Google Scholar 

  70. Estaki, M. et al. Cardiorespiratory fitness as a predictor of intestinal microbial diversity and distinct metagenomic functions. Microbiome 4, 1–13 (2016).

    Article  Google Scholar 

  71. Barton, W. et al. The microbiome of professional athletes differs from that of more sedentary subjects in composition and particularly at the functional metabolic level. Gut https://doi.org/10.1136/gutjnl-2016-313627 (2017).

    Article  PubMed  Google Scholar 

  72. Mohr, A. E. et al. The athletic gut microbiota. J. Int. Soc. Sports Nutr. 17, 1–33 (2020).

    Article  Google Scholar 

  73. Mailing, L. J., Allen, J. M., Buford, T. W., Fields, C. J. & Woods, J. A. Exercise and the gut microbiome: A review of the evidence, potential mechanisms, and implications for human health. Exerc. Sport Sci. Rev. 47, 75–85 (2019).

    PubMed  Article  Google Scholar 

  74. Keohane, D. M. et al. Four men in a boat: Ultra-endurance exercise alters the gut microbiome. J. Sci. Med. Sport 22, 1059–1064 (2019).

    PubMed  Article  Google Scholar 

  75. Scheiman, J. et al. Meta-omics analysis of elite athletes identifies a performance-enhancing microbe that functions via lactate metabolism. Nat. Med. 25, 1104–1109 (2019).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

Download references

Acknowledgements

This work was carried out within the activities of the Canada Excellence Research Chair in Microbiome-Endocannabinoidome Axis in Metabolic Health, held by V. Di Marzo and funded by the Canadian Federal Government Tri-Agency (CERC programme) and the CFI Leaders fund. This work was also supported by the Sentinelle Nord program (Laval University) via its support to the International Mixed Unit -MicroMenu (VD). FR is funded by NSERC Discovery Grant (RGPIN-2020-03922). Computing was performed on Compute Canada infrastructure (FR, RRG2734). BL has received funding from the Canadian Institutes for Health Research (ongoing at the time of this work), FRQS (ongoing at the time of this work), The Ministère de la santé et des services sociaux (MSSS) du Québec (ongoing at the time of this work), Health Canada (ongoing at the time of this work), Agriculture and Agri-Food Canada (Growing Forward program supported by the Dairy Farmers of Canada [completed in 2017], Canola Council of Canada, Flax Council of Canada and Dow Agrosciences [completed in 2017], National Dairy Council [terminated in 2017], Atrium Innovations [Completed in 2019]). All authors have no conflict of interest.

Author information

Authors and Affiliations

Authors

Contributions

F.F., B.L., A.V., F.B., V.D.M. and F.R. designed the clinical trial. F.F., J.P. and F.R. supervised the clinical study. F.F., G.R., L.P., J.P., F.B. and F.R. contributed to the realization of the clinical study. I.B.J., G.Q.H.N., F.A.G.A., V.R., P.F. and C.M. performed laboratory analysis. I.B.J., G.Q.H.N. and F.R. performed bioinformatics and statistical data analysis. F.F., B.L., N.F., A.V., F.B., V.D.M. and F.R. interpreted data. F.F., V.D.M. and F.R. wrote the manuscript. B.L., N.F., A.V., F.B., V.D.M. and F.R. supervised the study in their area of expertise. F.R. supervised the project as a whole. All authors provided critical feedback, and read and approved the final version of the manuscript.

Corresponding author

Correspondence to Frédéric Raymond.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Forteza, F., Bourdeau-Julien, I., Nguyen, G.Q. et al. Influence of diet on acute endocannabinoidome mediator levels post exercise in active women, a crossover randomized study. Sci Rep 12, 8568 (2022). https://doi.org/10.1038/s41598-022-10757-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41598-022-10757-0

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing